Genome Web Breaking News
- In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More
- People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More
- New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More
- New Products Posted to GenomeWeb: NanoString, Sophia Genetics, Lybe Scientific, More
- Support for Moderna Booster
Stat
- STAT+: Biogen drug for rare form of ALS fails pivotal study — another setback for fatal disease with few treatments
- Opinion: Historic yet imperfect: Malaria vaccine brings hope but the fight is far from over
- FDA advisory panel votes 19-0 to endorse booster dose of J&J vaccine
- STAT+: Up and down the ladder: The latest comings and goings
- STAT+: Pharmalittle: FDA panel recommends Moderna Covid booster shots; Biden eyes Califf as FDA commish
NYT science news
- West Virginia Leads U.S. in Flood Risk, Adding to Manchin’s Climate Dilemma
- Anni Bergman, Therapist Who Listened to Children, Dies at 102
- Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?
- Russian Film Crew Wraps Space Station Shoot and Returns to Earth
- Democrats Weigh Carbon Tax After Manchin Rejects Key Climate Provision
Fierce Biotech
- Agenus cell therapy spinoff MiNK inks mark on Wall Street with low-end $40M IPO
- NIH deals out $77.7M to develop 12 new rapid COVID diagnostics from BD, Quidel and more
- Roche welcomes PathAI into its open digital pathology initiative
- Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite
- FDA adds Class I recall label to Abbott Alinity COVID tests after risk of false positives
Fierce Medical Devices
- NIH deals out $77.7M to develop 12 new rapid COVID diagnostics from BD, Quidel and more
- Roche welcomes PathAI into its open digital pathology initiative
- FDA adds Class I recall label to Abbott Alinity COVID tests after risk of false positives
- Hologic dreams bigger for Bolder Surgical with $160M acquisition deal
- Cue Health snags the rebound, reupping NBA COVID testing contract for another season